Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank

Abstract

Background Frailty has been associated with worse prognosis following COVID-19 infection. While several studies have reported the association between frailty and COVID-19 mortality or length of hospital stay, there have been no community-based studies on the association between frailty and risk of severe infection. Considering that different definitions have been identified to assess frailty, this study aimed to compare the association between frailty and severe COVID-19 infection in UK Biobank using two frailty classifications: the frailty phenotype and the frailty index. Methods A total of 383,845 UK Biobank participants recruited 2006–2010 in England (211,310 [55.1%] women, baseline age 37–73 years) were included. COVID-19 test data were provided by Public Health England (available up to 28 June 2020). An adapted version of the frailty phenotype derived by Fried et al. was used to define frailty phenotype (robust, pre-frail, or frail). A previously validated frailty index was derived from 49 self-reported questionnaire items related to health, disease and disability, and mental wellbeing (robust, mild frailty, and moderate/severe frailty). Both classifications were derived from baseline data (2006–2010). Poisson regression models with robust standard errors were used to analyse the associations between both frailty classifications and severe COVID-19 infection (resulting in hospital admission or death), adjusted for sociodemographic and lifestyle factors. Results Of UK Biobank participants included, 802 were admitted to hospital with and/or died from COVID19 (323 deaths and 479 hospitalisations). After analyses were adjusted for sociodemographic and lifestyle factors, a higher risk of COVID-19 was observed for pre-frail (risk ratio (RR) 1.47 [95% CI 1.26; 1.71]) and frail (RR 2.66 [95% CI 2.04; 3.47]) individuals compared to those classified as robust using the frailty phenotype. Similar results were observed when the frailty index was used (RR mildly frail 1.46 [95% CI 1.26; 1.71] and RR moderate/severe frailty 2.43 [95% CI 1.91; 3.10]). Conclusions Frailty was associated with a higher risk of severe COVID-19 infection resulting in hospital admission or death, irrespective of how it was measured and independent of sociodemographic and lifestyle factors. Public health strategies need to consider the additional risk that COVID-19 poses in individuals with frailty, including which additional preventive measures might be required.

COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry

“…Impaired functional capabilities rather than individual diseases characterized AF patients with a worse prognosis. In line with our findings, previous works showed that factors like history of falls and frailty were associated with both risk and severity of COVID-19 at older ages [20,21]. In 375 consecutive patients younger than ours (mean age: 66 years), disability in Basic Activities of Daily Living (BADLs) was a significant predictor of mortality even after adjustment for age, gender and the presence of comorbidities.…”

Sarcopenic obesity and the risk of hospitalisation or death from COVID-19: findings from UK Biobank

“…Records were linked to inpatient Hospital Episode Statistics and national mortality registers (latest mortality data were available up to 16 th February 2021). As per previous studies [4, 26], the outcome of interest was ‘severe COVID-19’. This was defined by a positive test result for SARS-CoV-2 in a hospital setting (i.e., participants whose tests were taken while an inpatient) or death with a primary cause reported as COVID-19 (ICD-10 code U07.1) in accordance with WHO guidance [27].…”

Nutritional and Behavioral Approaches to Body Composition and Low-Grade Chronic Inflammation Management for Older Adults in the Ordinary and COVID-19 Times

“…The results showed that regardless of which diagnostic measure was used, these patients had a higher risk for severe COVID-19 infection and more serious consequences. The authors suggest that the new guidance on how to protect individuals with frailty should be established emphasizing that more specific protective and preventive measures are required for them, especially in view of a predicted new COVID-19 outbreak [ 23 ]. Indeed, with the possible health consequences associated with OSA and reported so far, including disability, frailty, chronic poor health, increased falls and bone fractures, a lower quality of life, higher nursing home placement and morbidity and premature death [ 5 , 6 ], this syndrome could be the one to assess first in order to detect patients at higher risk.…”